亘喜生物宣布FasTCAR-T GC012F早线治疗多发性骨髓瘤的1期新药临床试验（IND）申请获美国FDA批准
2024-01-30 17:35:57一带一路 | 汉尔姆助力“埃塞俄比亚奥罗米亚合作银行新总部大楼项目”建设
2024-01-30 17:34:49New Mountain Capital Opens Tokyo Office
2024-01-30 17:33:59KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Aw
2024-01-30 17:19:49Takeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating P
2024-01-30 17:18:46WillScot Mobile Mini to Acquire McGrath RentCorp for $3.8 Billion
2024-01-30 17:06:28随机文章
